Douglas Raymond offentlig
[search 0]
Download appen!
show episodes
 
Artwork

1
MedEdTalks - Ophthalmology

Vindico Medical Education

Unsubscribe
Unsubscribe
Månedligt
 
MedEdTalks Ophthalmology is an accredited educational podcast for providers to learn more about treating patients with Ophthalmology diseases/disorders. Discover all content and topics by visiting mededtalks.com.
  continue reading
 
Loading …
show series
 
In this podcast, expert clinicians will discuss new efficacy, safety, and durability data on dosing regimens, delivery systems, and emerging therapies for the treatment of neovascular age-related macular degeneration (nAMD). https://www.healio.com/cme/mededtalks/ophthalmology/20240729/2-the-retina-radar-with-dr-arshad-khanani-namd-management-in-202…
  continue reading
 
In this podcast, expert clinicians will discuss ongoing clinical trials and the latest data regarding advances in vitreoretinal care. https://www.healio.com/cme/mededtalks/ophthalmology/20240729/1-the-retina-radar-with-dr-arshad-khanani-clinical-trials-at-the-summit-2024
  continue reading
 
In this podcast, expert clinicians will discuss best practices for genetic testing and counseling for patients with IRDs, including interprofessional approaches and collaboration. https://www.healio.com/cme/mededtalks/ophthalmology/20240108/2-genetic-testing-and-counseling-for-irds
  continue reading
 
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with neovascular age-related macular degeneration, dry age-related macular degeneration, and geographic atrophy.
  continue reading
 
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibi…
  continue reading
 
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibi…
  continue reading
 
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibi…
  continue reading
 
Loading …

Hurtig referencevejledning